ABSTRACT
Introduction
In the past decades organic algae dietary supplements consisting of cyanobacteria or green algae were increasingly consumed for their putative beneficial health effects. These supplements are marketed among other things for athletes, pregnant or breast-feeding women, vegetarians, and during times of stress and weight loss. They were also advertised as detoxifiers, energy sources or as mood improvers. In some instances, in the case of Aphanizomenonj/os-aquae based cyanobacterial products, they were even marketed specifically for use in children, i.e. for the treatment of the Attention Deficit Hyperactivity Disorder. To date none of the beneficial effects could be scientifically and clinically confirmed. Moreover, the FDA mandated that companies selling cyanobacterial dietary supplements clearly state that these products have no pharmaceutical or curative capabilities: "This product is not intended to diagnose, treat, cure or prevent any disease".
Algae dietary supplements can be divided into three main groups:
(1) (2) Spirulina platensis and (3) Chlorella pyrenoidosa products.
The first group member is mainly harvested from an open environment, i.e. large lakes. The Upper Klamath Lake, Oregon, USA, is one of the most used sources for Aph.j/os-aquae, where the toxic cyanobacterial These algae dietary products are frequently consumed by humans in larger quantities and over longer periods of time, as suggested by the producers of these products, thereby inadvertently increasing the consumer's risk of a critical exposure to algae toxins and consequently potentially serious health effects. Indeed, according to the court hearing No. CV 08-3027-PA, United States District Court, District of Oregon. March 4, 2010 "U. S. v . KOLLMAN" (UNITED STATES OF AMERICA, Plaintiff, versus DARYL j. KOLLMAN, et aI., Defendants) , Cell Tech's (one of the major Aph. jlos-aquae based dietary supplement companies on Klamath Lake) gross receipts were more than $193,000,000 in 1996, achieved via sales across the United States and Canada through 350,000 individual distributors.
As a consequence, several studies were conducted in the last years to determine the degree of toxin contamination of algae dietary supplements as well as to evaluate the potential risk associated with the consumption of these products. As had to be expected, microcystins (MCs) were repeatedly detected in Aph.jlos-aquae products (Dietrich et aI., 2008; Fischer et aI., unpublished results; Gilroy et aI., 2000; Hoeger et aI., 2003; Saker et aI., 2005 Saker et aI., , 2007 Vichi et aI., 2012) . However, only a very limited number of studies broadened their toxin analyses to include several different types of toxins. In view of the "contamination" problem of algae dietary products and the potential of Aph. jlos-aquae to produce toxins by itself, a more in-depth understanding of the potential toxicities of algae dietary products is warranted. Indeed, the cyclic heptapeptide toxins (microcystins, MCs) are produced by several cyanobacteria including Anabaena and Planktothrix, whereas the pentapeptide cyclic toxins (Nodularins, Nod) are primarily produced by Nodularia (Pearson et aI., 2010) . Saxitoxin (STX) is a neurotoxin, known as a product ofcertain species of marine dinoflagellates, but also produced by freshwater cyanobacteria (Anabaena, Aphanizomenon, Cylindrospermopsis, Lyngbya, Planktothrix) (Clark et aI., 1999; Landsberg, 2002; Pearson et aI., 2010) .
Anatoxin-a (ATX) is a neurotoxic secondary, bicyclic amine alkaloid produced by at least four different genera of cyanobacteria (Ballot et aI., 2010a, 201Ob; Selwood et al., 2007) . Cylindrospermopsin (CYN) is a toxic polycyclic uracil derivative produced by a variety offreshwater cyanobacteria, e.g. Aphanizomenon, which is a common genera in temperate lakes (Fastner et aI., 2007; Pearson et aI., 2010) . Obviously, and based on above description of the potential toxin producers, algae dietary products could potentially be contaminated with all of the above toxins.
Consequently, we analyzed thirteen products of different brands available on the German market in 2010 consisting of Aph. jlos-aquae, Spirulina and Chlorella for the presence of MC, STX, ATX and CYN using a protein phosphatase inhibition assay, ELlSA, and LC-MS/MS. In Table 1 List of samples. (18 solid phase extraction (SPE) was performed according to manufacturer's instructions (Waters GmbH, Eschborn, Germany) in order to puril'y and concentrate MCs in the extracts. Briefly, the SPE columns were preconditioned with 100% MeOH (2x5 mL) and equilibrated with deionized water (2 x 3 mL). Extracts were applied and the SPE columns washed with deionized water (3x4 mL). MC-elution was achieved with 100% Me OH (3x4.5 mL). The collected eluates were evaporated to dryness via vacuum centrifugation. Dried extracts were re-suspended in 600 ).IL 100% MeOH, vigorously mixed, sonicated for 7.5 min and 2400 ).IL deionized water added. This mixture was sonicated and centrifuged at 13,000 xg for 20 min at RTto remove particles and extracts then stored at -20°C until further analysis.
Colorimetric protein phosphatase inhibition assay (cPPlA).
The cPPIA was performed according to Heresztyn and Nicholson (2001) with slight modifications. PPl instead of PP2 was used with a final concentration of 3 U mL -1 and the incubation time was increased to 5 h. Algae extracts were diluted serially with final dilution factors ranging from 1 to 729. Assay calibration was achieved with MC-LR (0.01-5 J.lg 1-1), the 100% control (100% color development) and the 0% control (assay background) were run on every plate. All extracts, standards and controls were assayed in duplicates on each plate and all analyses were conducted at least three times independently. Measurements were performed in a microplate reader (Infinite M200, Tecan, Crailsheim, Germany).
Adda-ELlSA. All extracts were analyzed using a commercially available Adda-ELISA kit (Abraxis LLC, Warminster, PA, USA; cat# 520011) according to the manufacturer's instructions. This indirect competitive ELISA recognizes specifically the Adda-moiety present in MC and nodularin molecules thus detecting the toxins in a congenerindependent mode (Fischer et aI., 2001) . All extracts were analyzed in duplicates on each plate and analyses were independently replicated at least three times. Toxin concentrations were calculated based on the MC-LR standard calibration curve (0.15-5 Ilg L -I) and are given as MC-LR equivalents (MC-LR eq ). The limit of detection (LOD) was 0.01 Ilg L -1 according to the manufacturer. Absorbances were read in a microplate reader (Infinite M200, Tecan, Crailsheim, Germany).
Cell culture and cytotoxicity experiments. A549 cells (human alveolar basal epithelial cells) were obtained from the DSMZ, Braunschweig, Germany (#ACC 107) and were cultured in DMEM/F12, supplemented with 10% FBS, 25 mM Hepes and antibiotics (100,000 U L -1 penicillin, 100 mg L -I streptomycin) under standard conditions (37°C, 5% COz). For cytotoxicity experiments all extracts and stock solutions (MC, CYN, solvent) were sterilized by filtration (0.2 flill). Cytotoxicity of algae extracts was determined using the MTT reduction assay, as previously described (Dietrich et aI., 2001; Mosmann, 1983) . A549 cells were seeded into 96-well-plates at a density of 1 x 10 4 cells cm-z and the plates were incubated at 37°C for 48 h until confluence was nearly reached. Then medium (100).IL) was renewed and 50 ).IL of the algae extracts, the appropriate concentration of test substances or solvent, were added and serially diluted resulting in dilution factors of 3, 9, 27 and 81, corresponding to 41.7, 13.9,4.6 and 1.5 g dw algae product L -1. The final concentrations for MC-LR (negative control, due to a lacking MC-LR transporter (Fischer et aI., 2010) 7% (vlv) Tween 20 was used as assay control. The treated cells were incubated for 26 h at 37°C. After incubating the cells in the presence of MTT (250 J.lg mL -1) at 37°C for 1.5 h, the supernatant was discarded and the intracellular formazan was solubilized with 95% (v Iv) isopropanol! 5% (v/v) formic acid. Absorbances were read at 550 nm using a microplate reader (Infinite M200, Tecan, Crailsheim, Germany).
Liquid chromatography tandem mass spectrometry (LC-MS/MS) analyses.
All toxin analyses were carried out on an Agilent 1100 series HPLC system (Agilent Technologies, Waldbronn, Germany) coupled to a API 4000 triple quadrupole mass spectrometer (Applied Biosystems/MDS Sciex, Framingham, MA) equipped with a turbo-ionspray interface.
MCs and nodularins were analyzed according to Spoof et al. (2003) in SPE-purified algae extracts. The extract was separated using a Purospher STAR RP-18 end-capped column (30x4 mm, 3 flill particle size, Merck, Germany) at 30°C. The mobile phase consisted of 0.5% formic acid (A) and acetonitrile with 0.5% formic acid (B) at a flow rate of 0. For the analysis of ATX, CYN and STX as well as other paralytic shellfish poisons (PSPs), algae products were extracted (Dell'Aversano et aI., 2004) using a mixture of acetonitril, water and formic acid (75:14.9:0.1). The extracts were separated using a 5 flill, 2 x 250 mm TSKgel Amide-80 column (Tosohaas, PA, USA) at 30°C. The mobile phase consisted of water (A) and acetonitrile-water (95:5) (B), both containing 2.0 mM ammonium formate and 3.6 mM formic acid (pH 3.5); the flow rate was 0.2 mL min -1. The following gradient program was used for analysis of multiple toxins (CYN, AD<, STX, PSPs): 75% B for 5 min, 75%-65% B over 1 min, hold for 13 min, 65-45% B over 4 min, hold for 10 min. DNA extraction and PCR analysis. DNA extraction was performed according to Saker et al. (2005) with modifications. Briefly, approximately 10 mg of each algae product was used. Products were incubated with 500 ).ILextraction buffer (100 mM Tris-HCl (pH 7.4), 1% (w/V) potassium ethyl xanthogenate, 800 mM ammonium acetate, 20 mM EDTA and 1 % (w Iv) SDS) for 2 h at 65°C (vortexed after 1 h). Mixtures were then placed on ice for 10 min and centrifuged at 12,OOOxg for 10 min. The mixture supernatants were extracted twice (20 min, shaking at RT) with equal volumes of phenol/chloroform/isoamylalcohol (25:24:1) and centrifuged at 12,OOOxg for 10 min. The DNA was precipitated for 15 min at 4 °C from the aqueous supernatants using 1 volume of isopropanol and 1/10 volume of 4 M ammonium acetate. Centrifugation at 12,OOOxg for 20 min pelleted the DNA, which was washed once with 70% ethanol and air-dried. The final samples were re-suspended in 50 ).IL deionized water. PCR was carried out in 25 )lL samples containing 1 xTaq master mix (NEE, cat# M0270S), 2.5 mM MgCl z , 50 pmol of each primer (Table 2 ) and lOng DNA The PCa/PCj3 primer pair was used to amplil'y a 650 bp fragment from the phycocyanin operon common to all cyanobacteria (Saker et aI., 2007) .
Hep primers were used to amplil'y the mcyE gene, part of the microcystin and nodularin synthetase gene cluster, and thus present in all microcystin and nodularin producing cyanobacteria (AMT, mcyE) (Saker et aI., 2005) .
Amplification was performed with an initial denaturing step at 92°C for 2 min followed by 35 cycles of 95°C for 90 s, 52 or 56°C 
Results

Toxin analyses
The analysis of microcystins and nodularin by the three different methods cPPIA, Adda-ELlSA and LC-MS/MS were in good agreement, i.e. none of the results differed significantly from another achieved via a different method of analysis (Table 3) . Re-analysis of products with known levels of microcystin (MC-LR equivalents) contamination i.e. Aph04(PC1), AphOS(PC2) and Aph06(NC1), provided for values Table 3 Comparison of methods for the detection of MCs in algae products. Oata (cPPIA and Adda-ELlSA) represent means {three independent determinations run in duplicate)±standar.d deviation (SO): LC-MS/MS analyses were run three times for each sample, data is presented as means ± standard deviation (SO): dw. dry weight: n.d., not detectable due to high color quenching: WO. limit nearly identical to those determined years ago (Table 4) , thus confirming the reliability of the measuremepts as well as the stability of the compounds in the product samples. The six new Aph.flos-aquae samples all tested positive for microcystin contamination, ranging between 004 and 2.2 pg MC-LR.,q g-1 dw algae supplement (Table 3) . LC-MS/MS analysis revealed that the Aph. flos-aquae samples primarily contained MC-LR and most of them also had traces of MC-LA (Table 5 , Fig. 1 ).
Based on LC-MS/MS analyses, none of the algae dietary products (cyanobacteria and green algae) demonstrated the presence of anatoxin-a, cylindrospermopsin or paralytic shellfish poisons (PSPs) including STX (data not shown).
Determination of cytotoxicity
To determine potential non-MC specific cytotoxicity preliminary assays with MC-LR established a no-effect-concentration of :s; 1 0 pM at 26 h (EC o : 26h) of exposure (data not shown). In contrast, with the positive control for cytotoxicity, CYN, resulted in an EC SO ;26h = 20 pM (data not shown). As all pure extracts contained high amounts of MeOH (20% (v/V)), MeOH cytotoxicity was determined at the MeOH dilutions (dilution factors: df=3 (20% MeOH/3), 9 (20% MeOH/9), 27 (20% MeOH/27) and 81 (20% MeOH/81)) present in the algae extracts (see Materials and methods). No MeOH related cytotoxicity was observed (Fig. 2) . As there was no statistical difference between the various MeOH dilutions and the untreated control ( Fig. 2) , all ensuing cytotoxicity results of algae extracts were statistically compared to the untreated control.
In general, all algae extracts showed a high cytotoxicity when tested at low dilutions of the original extract (41.7 and 13.9 mg dw L -1), whereas low or no cytotoxicity was observed at higher dilutions (4.6 and 1.5 mg dw L -1) (Figs. 3-5) . Aph.flos-aquae (Fig. 3 ) and S. platensis (Fig. 4 ) extracts provided for a very similar toxicity pattern. Generally, C. pyrenoidosa extracts (Fig. 5 ) appeared to be less cytotoxic. Table 4 Overview of control samples for the detection of MCs in algae products. Adda-ELlSA data are means (from at least three independent determinations run in duplicate) ± standard deviation (SO): LC-MS/MS analyses were run three times for each sample, data is presented as means±standard deviation (SO However. cytotoxicity seemed to be strongly lot dependent for all algae prod uct extracts tested. The cytotoxicity detected was also confirmed microscopically, where sJigh t1y affected A549 cells presented with blebbing, vacuolization, single cell necrosis ( Fig. 6B) and severely affected cells presented with overt and widespread necrosis along with loss of cellular integrity (Fig. 6C) .
Detennination of cyanobacteria/ and MC-specific genes
PCR analysis (Fig. 7) corroborated the results obtained for MC analyses. The mcyE gene was not detectable in two cases only (Aph03, Aph09), despite that the toxin analysis was positive for MC.
For PCR control, the phycocyanin gene (a pigment from the light-harvesting phycobili protein family) was used as a marker for cyanobacteria. As expected, Aph. jlos-aquae products (with the exception of sample Aph06) presented strong bands and C pyrenoidosa products were negative. Ch/orella product ChloOl showed a strong positive band, which was expected due to the mixed nature of the product (91% C pyrenoidosa and 9% Aph. jlos-aquae according to the supplier). Unexpectedly S. p/atensis products were negative. However, the latter is not surprising as the primers employed (Table 2) were originally designed to detect the Aph.jlos-aquae phycocyanine gene (Saker et aI., 2005 (Saker et aI., , 2007 and therefore unlikely to be suitable for detection of the phycocyanin gene in S. p/atensis products.
Discussion
The analysis for the presence of cyanobacterial toxins (MCs, nodularins, saxitoxins, anatoxin-a and cylindrospermopsin) encompassed only algae dietary supplements marketed in Germany and thus only the three main types of algae generally used for the produc- (Table 3) , thereby confirming that a reliable determination of MC contamination of algae dietary supplements can be obtained with any of the methods used and presented in this paper. Additional corroboration of MC contamination was sought by confirming the presence of an MC-producing cyanobacteria. The latter was achieved by the detection of the mcyE gene, part of the microcystin and nodularin synthetase gene cluster, and thus present in all microcystin and nodularin producing cyanobacteria (AMT, mcyE) (Saker et aI., 2005) . With the exception in two products (Aph03 and Aph09), mcyE PCR product was demonstrated in all algae dietary supplements containing either 100% of Aph. jlos-aquae (Fig. 7) or a mixture containing Aph. jlos-aquae. Dietary supplements Aph03 and Aph09 did not allow for a detectable PCR product, despite that toxin analysis showed an MC contamination of the respective product extracts (Tables 3, 5 and 6). The latter may be due to an expression below the detection limit of the PCR method employed. Indeed, these products also had the lowest level of MC contamination when compared to the other products. Overall, the above data strongly suggest that MC-producing cyanobacterial species are present in the algae dietary supplement products analyzed and thus this explains the presence of MCs in the product extracts. 13.9 4.6 1.5
41.7 13.9 4.6 1.5
Algal product (mg dw/L) Fig. 3 . Cytotoxidty of Aphjlos-aquae extracts in A549 cells. M1T assay after 26 h of exposure; data represent means±SEM (from four independent determinations (n=4) run in technical duplicates); Two-way ANOVA with Bonferroni posttest with p<O.OOl ("').
p<O.Ol C').
The degree of MC contaminations found in the algae dietary supplements correspond well with those reported earlier for European (Hoeger and Dietrich. 2004; Vinogradova et al.. 2011; Vichi et aI., 2012; Fischer et aI., unpublished results) . US and Canadian (Gilroy et al.. 2000; Saker et al.. 2005 Saker et al.. . 2007 ) and Australian (Saker et al.. 2007) markets. Detailed MC analysis demonstrated that MC contamination consisted primarily of MC-LR and traces of MC-LA, again similar to the findings reported by earlier European analyses (Fischer et al.. unpublished results; Hoeger and Dietrich, 2004; Vichi et aI., 2012; Vinogradova et al.. 2011 ) and thus confirming that these products appear to stem from the same production area or even primary producer. Since their release on the market and subsequent to some public inquiries with regard to adverse health effects of these products, the producers of the Aph. jIos-aquae products have been repeatedly claiming that their products are safe. The latter statement was later amended with the more cautionary statement that the products are certified to have MC contamination below the regulatory limit of 1 J.tg MC eq g-l dw for BGA-containing products originally established by the Oregon Department of Health (ODH) and the Oregon Department of Agriculture (ODA) (Gilroy et aI., 2000) . A provisional tolerable daily intake (pTDI) of 0.04 J.tg MC-LReq/kg bw and day was established (Gilroy et al.. 2000) and was used by the WHO for calculation of guidance values such as the provisional guideline of 1 J.tg MC-LR L -1 for drinking water ( WHO. 1998 WHO. , 1999 . Similarly. this pIDI is currently used as regulatory guidance for maximal contamination and/or daily exposure dietary levels in many other countries (Mulvenna et aI., 2012) . However. while regulation in Oregon (USA) is at the level of the product (1 J.tg MC eq g-l dw for BGA-containing products), other countries e.g. Switzerland, regulate the products based on consumption and allow a maximum daily exposure for adults of 2 J.tg MC-LRe q and correspondingly lower amounts in children and infants (FOPH). Based on the pTDI, infants (5 kg), children (20 kg) and adults (60 kg) could tolerate a maximum exposure of 0.2, 0.8 and 2.4 J.tg MCs per day. respectively (Fromme et aI., 2000; Dietrich and Hoeger. 2005; Dietrich et aI., 2008) . However. as demonstrated in this study (Table 6 and Fig. 8 ) the maximum daily eXposure of adults. children and infants largely depends on the level of MC contamination in and the daily consumption recommended for the respective algae dietary supplement product. Moreover, Fig. 8 MCs are known for their acute hepatotoxic effects predominantly via inhibition of protein phosphatases (MacKintosh et aI., 1995) . Chronic effects include tumor-promotion (Humpage and Falconer. 1999; Nishiwaki-Matsushima et al.. 1992) . which has led to the classification of MC-LR as a potential human carcinogen (2B) by the International Agency for Research on Cancer (IARC) of the WHO (Grosse et al.. 2006) . Neurotoxic effects and an involvement of MC exposure in the onset and exacerbation of human neurodegenerative diseases are currently under debate and cannot be ruled out (Feurstein, 2011; Feurstein et aI., 2011; Li et aI., 2012) .
It is thus crucial to emphasize that current pTDI calculations do not include the potential neurotoxic effects. Moreover. the whole MC risk assessment is based on the toxicological dataset for one MC congener. namely MC-LR, only (Gilroy et al.. 2000 , 41.7 13.9 4.6, 1.5 Algal product (mg dw/L) congeners, some of which may have an overall greater toxicity than MC-LR (Dietrich et aI., 2008) . Indeed, congeners MC-LF and -LW although having similar pp inhibition capacities as MC-LR were demonstrated to be taken up via organic anion transporting polypeptides (Oatps) much faster and thus having an overall higher cytotoxicity in human transfected HEK 293 (Fischer et aI., 2010) and in murine neuronal cells (Feurstein et aI., 2011) . The latter emphasizes that the current ,;; In addition to the quantitative analysis of certain toxins, other potential adversely active ingredients of the supplements were investigated using a cell culture-based approach. For this, the human alveolar epithelial cell line A549 was chosen as it could be assumed that these cells do not possess cellular transporter systems enabling MC uptake (Oatps, Fischer et aI., 2005 Fischer et aI., . 2010 . Testing with MC-LR up to 10 f1M for 26 h of exposure resulted in no observable cytotoxicity thus confirming the latter assumption of absence of OATPs. Indeed. cells expressing the respective OAPTs would present with IC 50 values for MC-LR in the nM range (Fischer et al.. 2010) . Thus all algae dietary supplement product extract mediated cytotoxicity in the A549 cell system chosen (Figs. 2-6) can be considered to stem from extract components other than the solvent (MeOH) or toxins analyzed in the extracts (MCs. nodularins, saxitoxins, anatoxin-a and cylindrospermopsin). Indeed, dietary supplement product extract cytotoxicity was reported earlier (Bechelli et al.. 2011; Pane et aI., 2008; Smital et aI., 2011) and thus corroborate the present findings. Similar to the cell blebbing. single and multiple cell necrosis observed here. Bechelli et al. (2011) reported Spirulina and Aph. jlos-aquae product extract mediated apoptosis and changes in the cell cycle, but no formation of ROS. To date, the cytotoxic components in the dietary supplement extracts responsible for the effects observed have not been identified, albeit it is known that algae readily absorb heavy metals e.g. lead or mercury and can result in contamination levels in the harvested products in the range of!Jg g-l (Fugh-Berman, 2003). However. the overt cytotoxicity observed in the cell assays may provide an explanation for the acute adverse health effects such as nausea, vomiting, diarrhea, constipation and upset stomach reported by consumers of these products (Braun and Cohen. 2010) . Allergic reactions induding asthmatic wheezing. hay fever or conjunctivitis. and skin irritations have also been reported as have drug interactions with antihistamines. blood-thinners and diabetes medications. Several case reports exist that appear to corroborate the health risks associated with consumption of algae dietary supplements. Acute rhabdomyolysis was reported in a 28-year old man following ingestion of Spirulina supplements for one month (Mazokopakis et aI., 2008) , generalized seizures associated with hypercalcemia of a day-old baby was found to be related,to the mother's long-term consumption of Spirulina supplements (Moulis et aI., 2012) and anaphylaxis was reported in a 14-year-old adolescent who had previously experienced urticaria, labial oedema and asthma 6 h after consumption of five Spirulina tablets (Petrus et aI., 2010) .
Beyond the fact that open water surface cultivation or harvesting of algae products for production of dietary supplements always encompasses the chance that the final products may contain human pathogens, e.g. Cryptosporidia, Campylobacter and EHEC, this analysis Fig. 8 . Range between minimum and maximum MC exposures from algae dietary product (values dependent on method used for analysis) calculated as MC-LR.,q (flg/day) in comparison to the maximum tolerable daily exposures calculated for infants. children and adults. Calculations were based on the provisional tolerable daily intake (pTDt) of 0.04 pg MC/kg bw and day that had been used by the ODH (Gilroy et al.. 2000) and WHO (WHO. 1998 
